You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Adult Kidney Disease: Laboratory Testing (Lipid Profile)

Percentage of patients aged 18 years and older with a diagnosis of CKD (stage 3, 4 or 5, not receiving Renal Replacement Therapy (RRT)) who had a fasting lipid profile performed at least once within a 12-month period

Date Reviewed: November 23, 2013

Measure Info

NQF 1668NQF Endorsement Removed
Measure Type: 
Process
Measure Steward: 
Renal Physicians Association
Clinical Topic Area: 
Chronic Kidney Disease

Care Setting: 
Outpatient
Data Source: 
Claims
Electronic Health Records
Registry

ACP does not support NQF 1668: “Laboratory Testing (Lipid Profile).” The ACP guideline states that there is inconclusive evidence for periodic monitoring (i.e. lipid profile) in patients diagnosed with stage 1-3 CKD.